Invitation to participate in the VITamin D and OmegA-3 TriaL (VITAL)
|
Posted By: How May I Help You NC on March 19, 2012 Help Make A Difference In Your And Your Family's Health Vitamin D and Omega-3 Trial (VITAL Research Study) VITAL is a research study in a diverse population of 20,000 men (age 50 and older) and women (age 55 and older) across the United States to investigate whether daily supplements of vitamin D or omega-3 fatty acids (fish oil) reduce the risk of cancer, heart disease, and stroke in people without a history of these illinesses. WHY IS YOUR PARTICIPATION IN THE VITAL STUDY IMPORTANT? * Participation of African Americans in medical research studies is low, so preventive health guidelines are often based on studies of other racial/ethnic groups * Low vitamin D is associated with these health conditions, and African Americans have lower vitamin D levels than other ethnic groups due to darker skin and lower dietary intake * Omega-3 fatty acids are helpful for people who already have heart disease * It is not yet known whether vitamin D or omega-3 fatty acid supplements can lower the risk of a first heart attack, stroke, or cancer, or improve life expectancy * African Americans are more likely to die of heart disease, stroke, and certain types of cancer than any other racial/ethnic group THE VITAL STUDY WILL ASSESS WHETHER VITAMIN D OR OMEGA-3 FATTY ACID SUPPLEMENTS CAN IMPROVE THE HEALTH OF AFRICAN AMERICANS AND OTHERS For more information, please call Brigham and Women's Hospital, an affiliate of Harvard Medical School, at 1-800-388-3963 or visit www.vitalstudy.org If you enjoyed this article, Join HBCU CONNECT today for similar content and opportunities via email! |
Comments
More From This Author
Latest News
Popular News
|
|
North Carolina HBCU Unity DayShaw University - Elizabeth City State University - Johnson C. Smith University - Fayetteville State University - Livingstone College - North Carolina A&T State University - North Carolina Central Uni ...more
Reginald Culpepper • 105,078 Views • August 8th, 2016 |


